BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7040243)

  • 1. Prostaglandin-related renin release from rabbit renal cortical slices.
    Spokas EG; Wong PY; McGiff JC
    Hypertension; 1982; 4(3 Pt 2):96-100. PubMed ID: 7040243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of renin release by 6-oxo-prostaglandin E1 and prostacyclin.
    McGiff JC; Spokas EG; Wong PY
    Br J Pharmacol; 1982 Jan; 75(1):137-44. PubMed ID: 7042021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the effects of prostacyclin and 6-keto-prostaglandin E1 on renin release in the isolated rat and rabbit kidney.
    Schwertschlag U; Stahl T; Hackenthal E
    Prostaglandins; 1982 Jan; 23(1):129-38. PubMed ID: 7038776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandins and renin release: I. Stimulation of renin release from rabbit renal cortical slices by PGI2.
    Whorton AR; Misono K; Hollifield J; Frolich JC; Inagami T; Oates JA
    Prostaglandins; 1977; 14(6):1095-1104. PubMed ID: 341227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-Keto-prostaglandin E1 is more potent than prostaglandin I2 as a renal vasodilator and renin secretagogue.
    Jackson EK; Herzer WA; Zimmerman JB; Branch RA; Oates JA; Gerkens JF
    J Pharmacol Exp Ther; 1981 Jan; 216(1):24-7. PubMed ID: 7005428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandins and renin release: III. Effects of PGE1, E2 F2 alpha and D2 on renin release from rabbit renal cortical slices.
    Whorton AR; Lazar JD; Smigel MD; Oates JA
    Prostaglandins; 1981 Sep; 22(3):455-68. PubMed ID: 7029656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-keto-prostaglandin E1 is not equipotent to prostacyclin (PGI2) as an antiaggregatory agent.
    Miller OV; Aiken JW; Shebuski RJ; Gorman RR
    Prostaglandins; 1980 Aug; 20(2):391-400. PubMed ID: 6251513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-blind study of epoprostenol and 6-keto-prostaglandin E1 in man: effects of platelet aggregation and plasma renin.
    Miyamori I; Morise T; Yasuhara S; Takeda Y; Koshida H; Takeda R
    Br J Clin Pharmacol; 1985 Dec; 20(6):681-3. PubMed ID: 3912001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between PG and beta-adrenergic pathways to renin release in rat renal cortical slices.
    Henrich WL; Campbell WB
    Am J Physiol; 1984 Sep; 247(3 Pt 1):E343-8. PubMed ID: 6089584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Keto-prostaglandin E1 inhibits the aggregation of human platelets.
    Wong PY; McGiff JC; Sun FF; Lee WH
    Eur J Pharmacol; 1979 Dec; 60(2-3):245-8. PubMed ID: 393526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct action of prostaglandins on renin release from rat renal cortical slices.
    Suzuki S; Franco-Saenz R; Tan SY; Mulrow PJ
    Proc Soc Exp Biol Med; 1981 Apr; 166(4):484-8. PubMed ID: 7012843
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostaglandin releasing polymers - stability and efficacy.
    McRea JC; Ebert CD; Kim SW
    Trans Am Soc Artif Intern Organs; 1981; 27():511-6. PubMed ID: 7036503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of intravitreal and topical prostaglandins on intraocular inflammation.
    Kulkarni PS; Srinivasan BD
    Invest Ophthalmol Vis Sci; 1982 Sep; 23(3):383-92. PubMed ID: 7050005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The differential role of exogenous and endogenous prostacyclin in the control of renin release from dog renal cortical slices.
    Yatsu T; Kurosawa H; Satoh H; Hayashi M; Satoh S
    J Cardiovasc Pharmacol; 2004 Dec; 44(6):676-81. PubMed ID: 15550787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin-mediated renin release from renal cortical slices.
    Whorton AR; Lazar JD; Smigel MD; Oates JA
    Adv Prostaglandin Thromboxane Res; 1980; 7():1123-9. PubMed ID: 6989181
    [No Abstract]   [Full Text] [Related]  

  • 16. Stimulation of renin release from rabbit renal cortex by arachidonic acid and prostaglandin endoperoxides.
    Webber PC; Larsson C; Anggard E; Hamberg M; Corey EJ; Nicolaou KC; Samuelsson B
    Circ Res; 1976 Dec; 39(6):868-74. PubMed ID: 1000781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects.
    Jackson EK; Goodman RP; Fitzgerald GA; Oates JA; Branch RA
    J Pharmacol Exp Ther; 1982 Apr; 221(1):183-7. PubMed ID: 7038095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6-keto-PGE1 exhibits more potent bronchodilatory activity in the cat than its precursor, PGI2.
    Spannhake EW; Levin JL; Hyman AL; Kadowitz PJ
    Prostaglandins; 1981 Feb; 21(2):267-75. PubMed ID: 7012934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination from the circulation of cats of 6-keto-prostaglandin E1 compared with prostaglandins E2 and I2.
    Förstermann U; Neufang B
    J Pharm Pharmacol; 1983 Nov; 35(11):724-8. PubMed ID: 6139453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of 6-keto prostaglandin E1 in mammalian kidneys.
    Griffiths RJ; Moore PK
    Br J Pharmacol; 1983 May; 79(1):149-55. PubMed ID: 6347300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.